Ubiquitination of angiotensin-converting enzyme 2 contributes to the development of pulmonary arterial hypertension mediated by neural precursor cell–expressed developmentally down-regulated gene 4-Like-Reference-Cited by-同舟云学术

Ubiquitination of angiotensin-converting enzyme 2 contributes to the development of pulmonary arterial hypertension mediated by neural precursor cell–expressed developmentally down-regulated gene 4-Like

Published:2024-08-29 Issue:1 Volume:25 Page:
ISSN:1465-993X
Container-title:Respiratory Research
language:en
Short-container-title:Respir Res

Author:

Wang Rui,Wang Rui,Zhou Siqi,Liu Tianya,Dang Jingjing,Chen Qianmin,Chen Jingyu,Wang Zhiping

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

Jiangsu Provincial Medical Innovation Center

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s12931-024-02953-5.pdf

Reference52 articles.

1. Ruopp NF, Cockrill BA. Diagnosis and treatment of pulmonary arterial hypertension: a review. JAMA. 2022;327(14):1379–91. https://doi.org/10.1001/jama.2022.4402

2. Li H, Li X, Hao Y, et al. Maresin 1 intervention reverses experimental pulmonary arterial hypertension in mice. Eur J Pharmacol. 2022;179(22):5132–47. https://doi.org/10.1111/bph.15906

3. Coons JC, Pogue K, Kolodziej AR, Hirsch GA, George MP. Pulmonary arterial hypertension: a pharmacotherapeutic update. Curr Cardiol Rep. 2019;21(11):141. https://doi.org/10.1007/s11886-019-1235-4

4. Thompson AAR, Lawrie A. Targeting vascular remodeling to treat pulmonary arterial hypertension. Trends Mol Med. 2017;23(1):31–45. https://doi.org/10.1016/j.molmed.2016.11.005

5. Lu X, Zhang J, Liu H, et al. Cannabidiol attenuates pulmonary arterial hypertension by improving vascular smooth muscle cells mitochondrial function. Theranostics. 2021;11(11):5267–78. https://doi.org/10.7150/thno.55571